Navigation Links
The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients

- Data Presented at the 11th International Myeloma Workshop -

NORTH HOLLYWOOD, Calif., and KOS, Greece, June 29, 2007 /PRNewswire/ -- The International Myeloma Foundation (IMF) -- supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians -- today said that updated statistics reported at the 11th International Myeloma Workshop in Greece demonstrate improved survival for a wide range of myeloma patients. Among the findings, in patients who had relapsed after one or more previous treatments:

    -- REVLIMID(R) (lenalidomide) plus the steroid dexamethasone showed an

       unprecedented median survival of nearly three years (35 months) for

       patients previously treated with multiple myeloma in updated data

       pooled from two large randomized controlled Phase III trials evaluating

       more than 700 patients from nearly 100 clinical sites worldwide.


    -- VELCADE(R) (bortezomib), combined with cyclophosphamide and prednisone

       in an open label Phase II trial evaluating 13 patients demonstrated an

       overall response rate of 93 percent. At one year, 100 percent of

       patients were alive.


    -- And combining VELCADE plus REVLIMID (with a steroid) showed a response

       rate of 68 percent in a pilot study of heavily pretreated patients.

"It was 15 years ago this month that my husband Brian Novis lost his battle with myeloma, and the progress since that time is truly remarkable," said Susie Novis, president and co-founder of the IMF. "Brian was diagnosed when he was just 33 years old and lived only four years past his diagnosis. Today we have multiple options for treatment, and for many patients survival is being measured in years, not months, with an excellent quality of life."

The International Myeloma Workshop brings together myeloma experts from all over the world to review the lates
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Post Your Comments:
(Date:7/31/2015)... , July 31, 2015 ... 2015 market research report that provides an overview ... using data sourced from in-house databases, secondary and ... and needles market products pipeline spread across 124 ... with 73 tables and 5 figures is now ...
(Date:7/31/2015)... BOSTON , July 31, 2015  Boston ... children benefiting from 3D printing of their anatomy ... had life-threatening cerebrovascular malformations (abnormalities in the brain,s ... Reporting online today in the Journal ... use of 3D printing and synthetic resins to ...
(Date:7/31/2015)...  Xcelience, a contract development and manufacturing organization ... structured cash investment in Powdersize, a ... and powder size classification within the pharmaceutical industry.  ... simultaneously adding a complete set of particle size ... "As we continue to build our ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 53D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... , , , , ... - StemEx Study is Enrolling Patients at Cord Blood Transplant Centers ... Israel . , Elbit Imaging Ltd. (NASDAQ: EMITF ... diluted basis),Gamida Cell Ltd. ("Gamida Cell") through the Gamida-Teva Joint Venture (JV),announced today ...
... NEW YORK and TOKYO , Feb. 9 ... iCyt Mission Technology, Inc. (iCyt), a leading producer of high-performance cell ... subsidiary, Sony Corporation of America (SCA).  With this acquisition, Sony is ... in the life science field.  iCyt, founded in 1995 and headquartered ...
Cached Medicine Technology:Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 4Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 5Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 2Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 3
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the network ... their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been ... companies have agreed to join their missions of purpose together to change the course ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... BeverlyD, owner ... the March4thforWellBeing foundation, making hers the very first small business donation to kick off ... beautiful for over thirty years. Her legacy includes a complete line of raw, organic ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... MGM Grand Garden Arena. Fans of every genre of music will have an act ... the first day of the festival, the following artists will perform: Sam Smith, Coldplay, ...
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... which is currently going on in Chicago at Grant Park. The festival ... every corner of North America to Chicago for the annual Lollapalooza. This unique ...
(Date:7/31/2015)... ... , ... The 2nd annual Ride to Fight On will start and end ... The Ride to Fight On is a cycling fundraiser that benefits the West Cancer ... and The University of Tennessee Health Science Center. A health and wellness festival featuring ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... has been warned to stop drinking. ,According to dailysnack.com, Spears ... damage to her kidneys, liver and other organs. ... the wagon, I don't think you will live. If you don't ... ,He added: "She wants to stop. She's changed her ...
... humans distant ancestors won the battle against the now extinct ... human species vulnerable to HIV today. AIDs one of ... of the most researched one still leaves many questions unanswered ... to the origin could be found in the jungles of ...
... Helder claro a pet shop owner was sentenced to two ... deadly cobra forced the evacuation of a rooming house beside ... counts of sexual assault and one count of sexual exploitation. ... groped them on several occasions in 2005 while briefly working ...
... have died of the feared H5N1 strain of bird flu, a ... total of 14 birds tested positive for the H5N1 strain of ... official, Katja Guenther, said earlier that tests carried out by the ... been infected with H5N1. ,Tests were still being conducted on ...
... to trade shows are an indicator of an industry's health, ... world's biggest wine and spirits fair, confirms the sector is ... 50,000 people attended this year's show, a two-yearly event in ... recent study conducted for Vinexpo by the London-based International Wine ...
... International Diabetes Federation (IDF) today called for projects that ... with diabetes and to implement practical solutions for improving ... as BRIDGES (Bringing Research in Diabetes to Global Environments ... Congress in Cape Town, South Africa and was officially ...
Cached Medicine News:Health News:Ancient Ancestors Might Have Had a Clue to HIV 2Health News:Two Year Probation for Cobra Owner Helder Claro 2Health News:Six Cases of H5N1 Bird Flu Confirmed in Germany 2Health News:World Wine Sales Brisk, but French Producers Hungover 2Health News:World Wine Sales Brisk, but French Producers Hungover 3Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 3
... patented Orion incorporates superior optics in a ... The fully adjustable headband, made of white ... on the brow, directing the spot along ... on the headband position the cable diagonally ...
... Bring the clarity of daylight into the ... Light Source. Designed for a variety of ... instruments, and video equipment - this light ... 300 watts (6,000o K) for superb tissue ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
Medicine Products: